The incorporation into DNA of 5-bromocytosine and 5-iodocytosine, derived from their respective administered deoxyribonucleoside analogs, has been demonstrated in studies with cells infected with herpes simplex virus types 1 and 2 (HSV-1 and little) incorporation of this analog as such in the DNA of HSV-1-and HSV-2-infected and -transformed cells. This suggests an exclusion or repair mechanism preventing inappropriate methylcytosine incorporation in DNA. The addition of nucleoside and deoxyribonucleoside deaminase inhibitors, which leads to the incorporation of 5-halogenated analogs of deoxycytidine into DNA as such, does not impair their antiviral activity. We infer from studies with 4-N-alkyl (ethyl and isopropyl)-substituted analogs of iododeoxycytidine that they are incorporated as such into DNA without deamination and effectively inhibit the virus at concentrations that are marginally toxic. Among the several reasons presented for the heightened potential efficacy of analogs of deoxycytidine compared with those of deoxyuridine is that the former, as analogs of 5-methyldeoxycytidine, may impair viral replication by perturbing processes involving methylation and changes in the methylation of deoxycytidine in DNA which appear to be important for the process of HSV maturation. In addition, this capacity to perturb methylation may, in turn, be the key to their potential as agents affecting entry into or emergence from latency, a process in which dramatic changes in the postpolymer 5-methylation of deoxycytidine occur in the DNA of herpesviruses.
The incorporation into DNA of 5-bromocytosine and 5-iodocytosine, derived from their respective administered deoxyribonucleoside analogs, has been demonstrated in studies with cells infected with herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and in cells transformed with the thymidine kinase gene of HSV-1. No significant incorporation of iodocytosine or iodouracil occurred in the DNA of uninfected or nontransformed cells when the deaminating enzymes were inhibited, in accord with past studies in our laboratory with 5-bromodeoxycytidine and tetrahydrouridine. When 2'-deoxytetrahydrouridine, a potent inhibitor of cytidine deaminase and dCMP deaminase, was utilized, all the counts in DNA that were derived from [125I]iododeoxycytidine appeared as iodocytosine in HSVinfected cells. In the absence of a deaminase inhibitor, 32 to 45% of the counts associated with DNA pyrimidines appeared as iodocytosine, and 55 to 68% appeared as iodouracil in HSV-infected cells. Substantial incorporation of iodocytosine (16%) occurred in cells transformed with the HSV thymidine kinase gene, suggesting the importance of the specificity of cellular nucleoside kinases and the activity of the deaminases in presenting unmodified bases to an undiscriminating polymerase. Incorporation into DNA of bromocytosine derived from [3H] bromodeoxycytidine was demonstrated in HSV-2 infected cells; very little incorporation of bromocytosine compared with bromouracil could be demonstrated in these cells in the absence of inhibition of the deaminases (19% of the total counts associated with pyrimidines with deaminase inhibition and 1.5% without). Limited studies with 5-methyl [5-3H] deoxycytidine indicated essentially no (or very little) incorporation of this analog as such in the DNA of HSV-1-and HSV-2-infected and -transformed cells. This suggests an exclusion or repair mechanism preventing inappropriate methylcytosine incorporation in DNA. The addition of nucleoside and deoxyribonucleoside deaminase inhibitors, which leads to the incorporation of 5-halogenated analogs of deoxycytidine into DNA as such, does not impair their antiviral activity. We infer from studies with 4-N-alkyl (ethyl and isopropyl)-substituted analogs of iododeoxycytidine that they are incorporated as such into DNA without deamination and effectively inhibit the virus at concentrations that are marginally toxic. Among the several reasons presented for the heightened potential efficacy of analogs of deoxycytidine compared with those of deoxyuridine is that the former, as analogs of 5-methyldeoxycytidine, may impair viral replication by perturbing processes involving methylation and changes in the methylation of deoxycytidine in DNA which appear to be important for the process of HSV maturation. In addition, this capacity to perturb methylation may, in turn, be the key to their potential as agents affecting entry into or emergence from latency, a process in which dramatic changes in the postpolymer 5-methylation of deoxycytidine occur in the DNA of herpesviruses. 466 FOX, DOBERSEN, AND GREER the fact that the 5-substituted 2'-dCs have attracted relatively little attention as potential antiviral agents and stated that they had confirmed the contention of Greer and his colleagues (10, 15, 16, 20, 24, 43 ) that 5-halogenated analogs of dC are indeed more selective inhibitors of herpes simplex virus (HSV) replication than are the analogs of dU.
Tetrahydrouridine (H4U), an inhibitor of cytidine deaminase (4) , was used in our past studies to prevent conversion at the nucleoside level in a strategy that exploited our findings that the 5-halogenated analogs of dC are poor substrates for mammalian dC kinase and thymidine kinase (TK) (11, 12) but are effective substrates for the pyrimidine nucleoside kinase of HSV (10, 15) and varicella-zoster virus (16, 23) . Although cytomegalovirus does not possess a virus-encoded enzyme capable of phosphorylating 5-halo(dC) analogs (24) , the dC analogs are nonetheless more effective than analogs of dU against this virus (24, 45) . As nucleotides, the dC analogs are substrates for deoxycytidylate (dCMP) deaminase (which is only moderately inhibited by H4U), resulting in the formation of the thymidylate analog. It has been inferred that viral inhibition results when this deaminated metabolite is further anabolized to the inhibitory triphosphate in infected cells.
We were interested in examining the possibility that 5-halogenated and 5-methylated analogs of dC might be incorporated as such into the DNA of HSV-infected and HSV-transformed cells. In the present study we utilized 2'-deoxytetrahydrouridine (2'-dH4U), an inhibitor of both cytidine deaminase and dCMP deaminase that was first utilized by Maley and Maley (30) . This intermediate-state analog must be anabolized by the target cell to 2'-dH4UMP by a phosphotransferase (31) to inhibit dCMP deaminase effectively (Ki = 10-8 to 2 x 10-8 M).
The use of 5-substituted analogs of dC makes it possible to determine (for cells transformed by the HSV TK gene) the roles of the host DNA polymerase on the one hand and the nucleoside and nucleotide kinases and converting enzymes on the other, in maintaining the base modification patterns in DNA. This is an important consideration in view of the degradation of DNA, as well as mRNA and heterogenous nuclear RNA containing 5-methylcytosine (40, 42) .
Making the reasonable assumption that the 5-halo(dUXP) metabolites result in greater toxicity than 5-halo(dCXP) metabolites, the use of dH4U offers greater selectivity with 5-halogenated analogs of dC that may be partially anabolized in uninfected cells by dC kinase, for dH4U inhibits the formation of the 5-halo(dUMP) analog. For example, 5-bromo(dUTP) is a potent inhibitor of nucleoside diphosphate reductase (32) . Heightened efficacy could be achieved only if the 5-halo(dCMP) analog retained a great portion of its antiviral activity when further anabolized to the cytidine deoxyribonucleoside triphosphate; it is this question of increased efficacy that the present study addresses. Another way to prevent deamination to achieve greater efficacy was explored in these studies by utilizing analogs with 4-amino substitutions that result in intrinsic resistance to deamination.
The studies of Summers and Summers (47), who described a simple assay for the presence of the HSV TK gene based on findings from our laboratory (10) , have led to the general use of 5-iodo(dC) (IdC) with H4U to detect and characterize the regulation of the HSV TK gene in studies involving recombinant DNA technology (35, 39a Hydrolysis and chromatography of dried acid-insoluble material. Dried acid-insoluble material was hydrolyzed in 0.05 ml of 7.5 N perchloric acid (PCA) at 100°C for 1 h. Less than 0.5% deamination of iodocytosine occurs under these conditions of hydrolysis. The resulting solution was neutralized with 0.06 ml of 7.5 N NaOH, particulate matter was removed by pelleting, and 20 ,ul of the hydrolysate was spotted on Whatman 3MM paper. lodouracil and iodocytosine were added as carrier bases, and resolution was achieved by descending chromatography with isopropanol-HCl-water (170:41:39) for 20 h (Rf) of iodouracil, 0.80; Rf of iodocytosine, 0.48). Radiation was assayed without scintillant in a Shearle descending-well gamma counter by counting for 2 min.
[123I]IdC incorporation experiments with LH7 cells.
LH7 cells (36) were grown for 48 h in media containing 7 ,Ci of [125I]IdC per 10-cm plastic tissue culture dish.
The washed monolayers from 10 plates were scraped, pooled, and hypotonically lysed by suspension for 12 h in 10 mM Tris-hydrochloride (pH 7.4)-0.005 mM RNase A-0.1% Nonidet P-40-10 mM NaCl. Nuclear and mitochondrial fractions were separated by sequential centrifugations at 500 x g and 10,000 x g after the addition of 20 ml of 0.6 M sucrose buffer in 25 mM Tris-hydrochloride (pH 7.4)-2 mM EDTA (34). Pellets were dissolved in 0.5% Sarkosyl-0.5% sodium dodecyl sulfate, DNA was hydrolyzed, bases were chromatographically separated, and radioactivity was determined as described above. Each chromatographic track was cut into 1-cm segments, and the gamma emission of each segment was assayed.
[3H]BrdC incorporation studies with HSV-2-infected BHK cells. BHK monolayers were infected at a multiplicity of 3 and were incubated for 1 h with agitation. The inoculum was then washed off, and medium containing 10o fetal calf serum was added.
After 1 h more (2 h postinfection), the monolayer was washed twice with PBS, and medium was added containing 2'-dH4UMP. (dH4U was not available when these experiments were undertaken, and
[3H]BrdC was not available when dH4U was acquired). After 1 or 3 h of preincubation, [3H]BrdC (New England Nuclear Corp., Boston, Mass.; generally labeled at 210 ICi/mol) was added for a 2-h pulse at 37°C. The experiment was terminated by washing the monolayers twice with cold PBS and adding 5 ml of cold TCA to each plate. The resulting precipitate was washed three times with 10 ml of 5% TCA and was rinsed twice under 95% ethanol on glass-fiber filters. After drying, the total radioactivity derived from each dish was determined. The experiment was done in triplicate. The addition of dH4UMP did not affect the total counts in the TCA precipitate. Incubation of the TCA precipitate with 0.5 N NaOH for 18 h at 37°C did not change the total radioactivity. The TCA precipitate was hydrolyzed from the glass-fiber filters with VOL. 23, 1983 The effects of H4U and dH4U on the cytotoxicity and anti-HSV-2 activity of IdC and the anti-HSV activity of 5-BrdC are shown in Table 2 . The addition of H4U results in a dramatic increase in cell survival, as we demonstrated in previous studies (20, 43) . In the case of BrdC, a slightly lower survival was obtained with dH4U than with H4U. This effect may be due to the effect of dH4U on lowering the levels of dUMP. The goal of heightened efficacy might be better served by a concentration range of both BrdC and dH4U at which cell survival would exceed that obtained with the coadministration of H4U. An examination of the results in Table 3 indicates that IdC-derived pyrimidines were recovered only as iodouracil in the DNA of uninfected cells when deaminase activity was not inhibited. No counts above the background level were recovered from uninfected cells pulsed in the presence of dH4U. Conversion of IdC to the thymidine analog was necessary for its incorporation into the DNA of uninfected cells. These results are consistent with the cytotoxicity data and previous studies from this laboratory (10-12, 15, 16) . In HSV-1-infected cells, IdC was incorporated as 5-iodocytosine or 5-iodouracil in the absence of dH4U, but only as 5-iodocytosine when deamination was prevented. To exclude the possibility that incorporation into RNA was responsible for the recovery of this TCA-precipitable material, alkaline hydrolysis ( with pronase, and the preparation was deproteinized. DNA was then precipitated, washed in ethanol, dried, and treated as indicated. After treatment with nucleases or KOH, the DNA was reprecipitated with TCA, dried, and hydrolyzed in 7.5 N PCA at 100°C for 1 h and was subjected to chromatographic analysis. washed monolayers from 10 plates were lysed, and nuclear and mitochondrial fractions were separated by differential centrifugation. Pellets were dissolved in Sarkosyl-sodium dodecyl sulfate, and the DNA was hydrolyzed for chromatographic analysis.
affect the extent and distribution of radiolabel, whereas treatment with DNase brought the counts down to background levels. The reduced counts in each succeeding experiment in Table 3 were due to the chemical decomposition of the [125I]IdC, discussed above. HSV-2 was utilized in HEp-2 cells in a study similar to that summarized in Table 3 . Without dH4U, significant incorporation of undeaminated IdC occurred: 55% of the counts associated with nucleic acid pynmidines was with iodouracil and 45% was with iodocytosine, essentially equal to the levels found with HSV-1-infected cells.
Incorporation studies with [125I]IdC in cells
transformed with the HSV TK gene. It is conceivable that the viral polymerase is essential for the incorporation of IdC into DNA. Alternatively, the mammalian DNA polymerase could also be capable of this incorporation, but the specificities of the nucleoside kinases limit the incorporation of IdC in uninfected cells, precluding a test of this hypothesis. We therefore employed the cell line LH7 (37) , in which a restriction fragment containing only the HSV-1 nucleoside kinase gene has been cloned. The original source of this gene was HSV-1 strain F. This is the same strain of virus that was utilized in the antiviral and incorporation studies. To eliminate the possibility that all the incorporation of IdC might be due to phosphorylation by mitochondrial TK and subsequent action of the mitochondrial DNA polymerase, which is known to readily incorporate thymidine analogs into DNA (15, 27) , separate mitochondrial and nuclear fractions were prepared. dH4U was not added in these studies since preliminary studies (with only one concentration of dH4U and IdC) indicated that dH4U blocks the incorporation of all IdC-derived counts into the DNA of this cell line. These results may be attributed to the elevated intracellular dCTP pools resulting from a decrease in the effector inhibition of nucleoside diphosphate reductase, which is due in turn to the decreased levels of TTP; this elevation of dCTP would, we propose, obliterate the incorporation of IdC into DNA. Diminished TTP levels in transformed cells result from inhibition of the formation of dUMP by dH4U. Evidence for this speculation is currently being investigated in biochemical studies. In HSV-infected cells, the levels of dCTP are low, whereas the levels of TTP are extremely high (22) ; furthermore, the reductase encoded by the virus is unresponsive to changes in the level of TTP (38) . This could explain the difference in results obtained with 6 (44) .
It is of interest that in HSV-infected cells, no counts above background associated with methylcytosine were detected with or without dH4U (and without the addition of formate). This is aAt 2 h after cells were infected at a multiplicity of 3, dH4UMP was added. After 1 or 3 h of preincubation with the deaminase inhibitor, [3H]BrdC (210 .CiYIpmol) was added for a 2-h pulse at 37°C, and the reaction was terminated by TCA precipitation. The precipitate was washed three times in TCA and twice in 95% ethanol and was subjected to acid hydrolysis, as described in Table 3 , footnote a, for chromatographic analysis.
VOL. 23, 1983 on June 29, 2017 by guest http://aac.asm.org/ DNA was prepared for chromatographic analysis as described in Table 3 , footnote a.
probably due to the fact that preformed nucleosides are utilized so extensively (the salvage pathway) in HSV-infected cells that very little formate is reutilized for pyrimidine ring biosynthesis. HSV-1-or HSV-2-infected cells that were grown for 3 days in 5-CH3[5-3HJdC had significant label in thymidine only. Addition of dH4U did not diminish the counts in thymidine of 3H derived from CH3dC. Consistent with the suggestion that these counts in thymidine are not derived from postpolymer deamination of CH3dC is the fact that the addition of unlabeled thymidine 2 h before the addition of [3H]CH3dC decreased the 3H counts in DNA thymidine by 95 to 99%. Thus, our limited studies with 5-CH3[5-3HjdC suggest that the source of the 3H label in the DNA of uninfected cells is entirely the result of deamination and subsequent catabolism of metabolites of CH3dC followed by recycling through the formate pool. Heightened salvage in infected cells would preclude extensive recycling of the labeled methyl group. An additional reason for the differences obtained between infected and uninfected cells is that mature viral DNA does not contain 5-CH3-cytosine.
DISCUSSION
The new principal of approaching heightened efficacy that emerges from these studies is to prevent deamination of the 5-substituted analogs of dC at both nucleoside and nucleotide levels. By adding 2'-dH4U or introducing alkyl substitutions at the 4-N position it is possible to incorporate these analogs into DNA as such. This has been demonstrated directly with IdC and BrdC and inferred with two of the 4-N-alkyl-substituted analogs. Even without the coadministration of an inhibitor of deamination, incorporation of iodocytosine was seen in the DNA of cells possessing high levels of cytidine and dCMP deaminase. This may be due, in part, to the fact that HSV TK is also a TMP kinase (5); therefore, the nucleotide may proceed to the diphosphate without leaving the enzyme, so that it is not accessible to dCMP deaminase.
A demonstration of the principal of achieving heightened efficacy by preventing deamination of the 5-substituted analogs of dC at both nucleoside and nucleotide levels was provided by experiments in which intrinsically deaminaseresistant IdC analogs were shown to inactivate HSV-2 significantly with only marginal toxicity in cell culture. The fact that these analogs continue to display their antiviral effect in the presence of dH4U leads us to believe that the 4-N analogs can be incorporated as such. These results suggest further insight into the broad specificity of the HSV nucleoside kinase on which we first reported several years ago (10) .
Not only will 4-NH2-5-halogenated pyrimidine analogs act as substrates for this enzyme, but extensive substitutions may be tolerated in the 4-N position. Because a number of substitutions at the 4-N position effectively prevent deamination of dC (28) , other 4-N substitutions should be examined; furthermore, substitutions at the 4 position itself may be fruitful. The coadministra-tion of dH4U with IdC did not reduce the anti-HSV activity of these analogs, suggesting that nucleotide-level deamination is not necessary for virus inactivation as previously thought (10, 20, 43 The counts associated with iodocytosine obtained with HSV-infected cells were presumed to exist in viral DNA. Indeed, the extraction procedures used would favor recovery of viral rather than host DNA (37) . The recovery of iodocytosine-associated counts from nuclear DNA of LH7 (HSV-1 TK-transformed) cells grown in the presence of [125I]IdC indicates that only the failure of 5-substituted dC nucleotides to form or their rapid deamination prevents their utilization by the cellular DNA polymerases in (nontransformed) mammalian cells.
The incorporation of IdC as such into DNA suggests that 5-methyl(dC) might be similarly incorporated. DNA methylation appears to regulate a variety of cellular functions (3, 7, 41) , and studies with 5-azacytidine used to alter methylation patterns and affect transcription and differentiated functions are consistent with this concept (8, 9, 25) . In view of the substantial 5-methylcytosine content in DNA (2 to 6% of cytosine residues are methylated [7] ) and the degradation of DNA that occurs in many cells, it is conceivable that 5-methyl(dC) and 5-methyldeoxycytidylate could be reutilized for DNA synthesis with devastating effects on cellular control and gene expression were it not for the specificity of the mammalian nucleoside kinase and the activities of cytidine and dCMP deaminase coupled with the high Km (0.6 mM) of dCMP kinase for its substrate, dCMP (the latter value was reported by Jackson [21] ). dCMP deaminase may play a critical role, not only by providing a source of dUMP for thymidylate synthetase (for which there is an alternate de VOL. 23, 1983 on June 29, 2017 by guest http://aac.asm.org/ 474 FOX, DOBERSEN, AND GREER novo pathway), but by preventing methyl(dCMP), which arises from the degradation of DNA, from being incorporated into DNA. The strategic location of ribonucleotide reductase at the diphosphate level rather than the monophosphate level may have resulted from the need (in the evolutionary sense) to expose the rare modified ribonucleoside monophosphates, which are derived from the processing of heterogenous nuclear RNA and the degradation of mRNA, to the discriminating substrate specificities of nucleotide kinases to prevent their incorporation into the genetic material at sites not specified by the enzymes of postpolymer methylation. In this regard, it would be of interest to determine whether 5-CH3CDP would serve as a substrate for the reductase and to determine how efficiently 5-CH3CMP is phosphorylated. In the studies of Creasey (13) (2), it may not in vivo. An unexpected exclusion occurs with RNA polymerase in the case of 5-fluoroCTP (19) . Another exclusion mechanism for which there is a precedent in bacteriophage-infected cells involves a dCTPase that is highly specific; in this case, it does not affect hydroxymethyl(dCTP) but does hydrolyze dCTP. These aspects of CH3dC involve considerations that go beyond the domain of viral chemotherapy and relate to current problems in molecular biology regarding regulation and differentiation.
The use of 5-halogenated analogs of dC, which have been shown to be potent antiviral agents (14; studies from this laboratory [10, 16, 18, 23, 24, 43] ), may Allow heightened efficacy in the management of productive infections. By coadministering inhibitors of their deamination or modifying the amino group so that deamination does not occur, the analog (i) will be a poor substrate for the mammalian nuceloside kinases but will be specifically phosphorylated by the HSV-encoded nucleoside kinase, unlike some dU analogs; (ii) will not be catabolized by uridine and thymidine phosphorylase, as are some analogs of dU; (iii) will not inhibit the host nucleoside diphosphate reductase as the triphosphate, as with E-5-propenyl(dUTP), an effective inhibitor of the host reductase (33) (counter to the goals of chemotherapy, these dU triphosphates may only weakly inhibit the effectorresistant nucleoside diphosphate reductase of HSV-infected cells); (iv) will not be dehalogenated at the nucleotide level by thymidylate synthetase, as is (for example) IdUMP (48) ; (v) will not inhibit thymidylate synthetase, an enzyme important for host but not for viral functions (a special situation for 5-nitro and 5-trifluoromethyl substitutions, for example); (vi) will allow the addition of dC, a selective antagonist that will allow heightened efficacy because it does not diminish the antiviral effect of these dC analogs, whereas it does diminish toxicity; (vii) will affect the methylation of DNA, which appears to be an important part of the maturation process of herpesviruses.
In view of recent experiments by Youssoufian et al. (49) , who found that cytosine in the DNA of herpesviruses is methylated at the 5-position in a model system that is analogous to the latent state and unmethylated during productive infection, the selective incorporation of 5-halogenated analogs of dC into DNA as such could affect entry into and emergence from the latent state. The approach with 5-halogenated analogs of dC might be fruitful even if the state of methylation does not determine whether the course of latency or productive infection is followed but is merely a distinguishing characteristic of two different states of the virus.
